Towards the elimination of iodine deficiency and preventable thyroid-related diseases in Europe
Acronym
EUthyroid
Description of the granted funding
Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food, Europe belongs to the worst regions in terms of access to iodized salt and is seriously ID, resulting in the perpetuation of the single most important, preventable cause of brain damage. European ID is due to significant heterogeneity in prevention and monitoring programs, leading to inappropriate interventions, increased disease burden, health inequities and increased health care costs. Up to 360 Million European citizens are exposed to ID disorders. An effective European monitoring program is a crucial step towards eradication of ID disorders with significant benefits for European citizens and the sustainability of health care systems. The effects of ID in total cause tremendous, preventable costs in health care systems of affected regions.
The overall aim of EUthyroid is to evaluate ID prevention and monitoring programs in 24 European countries, to initiate capacity building for harmonized European ID prevention and monitoring programs, and to disseminate project outcomes for supporting measures on national and EU level in order to eradicate ID disorders in Europe. The project will position itself as international hub of current national initiatives in the attempt to coordinate and support existing national activities. EUthyroid will generate the first harmonized data set of ID resulting in the first valid map of iodine status in Europe. With a dedicated dissemination program about the unfavorable health outcomes of ID, EUthyroid will pave the way for a harmonized EU-wide regulation of iodination, a common approach to iodine and outcome monitoring and establish recommendations for scientists on how to monitor IDD prevention programs. The project aims to make Europe a benchmark for ID disorder prevention worldwide.
Show moreStarting year
2015
End year
2018
Granted funding
UNIWERSYTET JAGIELLONSKI (PL)
22 492.5 €
Participant
OU ENDOKRINOLOOGIAKESKUS (EE)
11 270 €
Participant
IODINE GLOBAL NETWORK (CA)
13 973.58 €
Participant
ENDOKRINOLOGICKY USTAV (CZ)
20 177.5 €
Participant
UNIVERSITATSMEDIZIN GREIFSWALD KORPERSCHAFT DES OFFENTLICHEN RECHTS (DE)
572 602.42 €
Coordinator
CENTRE FOR REGIONAL POLICY RESEARCH AND COOPERATION STUDIORUM ZDRUZENJE
20 177.5 €
Participant
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (ES)
89 607.5 €
Participant
KLINICKI BOLNICKI CENTAR SESTRE MILOSRDNICE USTANOVA (HR)
11 125 €
Participant
MINISTERIO DA DEFESA NACIONAL (PT)
20 177.5 €
Participant
INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES)
20 165 €
Participant
HAVFORSKNINGSINSTITUTTET (NO)
31 506.25 €
Participant
VASTRA GOTALANDS LANS LANDSTING (SE)
17 875 €
Participant
REGION HOVEDSTADEN (DK)
272 963 €
Participant
REGION HOVEDSTADEN (DK)
272 963.75 €
Participant
BIOLUTION GMBH (AT)
376 276.43 €
Participant
LANDSPITALI UNIVERSITY HOSPITAL (IS)
11 276.25 €
Participant
UNIVERSITA DI PISA (IT)
11 270 €
Participant
LATVIJAS UNIVERSITATE (LV)
109 407.5 €
Participant
DEBRECENI EGYETEM (HU)
11 276 €
Participant
DEBRECENI EGYETEM (HU)
11 276.25 €
Participant
UNIVERZITETNI KLINICNI CENTER LJUBLJANA (SI)
19 875 €
Participant
SOFIA UNIVERSITY ST KLIMENT OHRIDSKI (BG)
21 125 €
Participant
PANEPISTIMIO PATRON (EL)
73 805 €
Participant
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (FR)
11 270 €
Participant
UMIT- PRIVATE UNIVERSITAT FUER GESUNDHEITSWISSENSCHAFTEN, MEDIZINISCHEINFORMATIK UND TECHNIK GMBH (AT)
398 812.19 €
Participant
THE HEBREW UNIVERSITY OF JERUSALEM (IL)
8 000 €
Participant
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH (CH)
Participant
UPPSALA UNIVERSITET (SE)
11 270 €
Participant
UNIVERSITY OF SURREY (UK)
185 338.13 €
Participant
UNIVERSITE LIBRE DE BRUXELLES (BE)
11 692.5 €
Participant
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (NL)
178 340 €
Participant
THE QUEEN'S UNIVERSITY OF BELFAST (UK)
20 177.5 €
Participant
Amount granted
2 999 949 €
Funder
European Union
Funding instrument
Research and Innovation action
Framework programme
Horizon 2020 Framework Programme
Call
Programme part
Health (5290 Preventing disease (5295 )
Topic
Evaluating existing screening and prevention programmes (PHC-06-2014Call ID
H2020-PHC-2014-two-stage Other information
Funding decision number
634453
Identified topics
brain, neuroscience